Jonathan Allan, GENERAL COUNSEL & Corporate Secretary at Stoke Therapeutics, Inc. (STOK), sold 17,718 shares at $32.74 ($569K) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Open-market sale of $569k STOK by GENERAL COUNSEL & Corporate Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.74 | 2,476 | $81K | 14.2% |
| 2 | $32.74 | 2,476 | $81K | 14.2% |
| 3 | $33.38 | 1,791 | $60K | 10.5% |
| 4 | $33.38 | 1,791 | $60K | 10.5% |
| 5 | $31.28 | 4,222 | $132K | 23.2% |
| 6 | $31.28 | 4,222 |
| $132K |
| 23.2% |
| 7 | $31.79 | 334 | $11K | 1.9% |
| 8 | $31.79 | 334 | $11K | 1.9% |
| 9 | $32.85 | 72 | $2K | 0.4% |
| Total | $32.14 avg | 17,718 | $569K | 100% |
| Filing → |
| STOK | SELL | 2026-06-18 | $44K | — | Filing → |
| STOK | SELL | 2026-03-24 | $626K | — | Filing → |
| STOK | SELL | 2025-12-10 | $216K | — | Filing → |